Validation of the Data Quality of a Tumor Board Registry Through Assessment of Clinicopathologic Survival Outcomes in Melanoma Patients.
Ligtenberg KG, Chartash D, Bosenberg M, Brandt C. Validation of the Data Quality of a Tumor Board Registry Through Assessment of Clinicopathologic Survival Outcomes in Melanoma Patients. AMIA Annual Symposium Proceedings 2021, 2020: 747-755. PMID: 33936449, PMCID: PMC8075482.Peer-Reviewed Original Research